Marinus Pharmaceuticals, Inc. (MRNS)
USD 0.55
(0.0%)
USD 0.55
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 30.98 Million | 25.47 Million | 15.34 Million | 1.71 Million | - | - |
| Cost of Revenue | 1.93 Million | 340 Thousand | 1.47 Million | 50.5 Million | 503 Thousand | 127 Thousand |
| Gross Profit | 29.05 Million | 25.13 Million | 13.86 Million | -48.78 Million | -503 Thousand | -127 Thousand |
| Operating Expenses | 160.54 Million | 137.92 Million | 110.79 Million | 69.65 Million | 54.42 Million | 37.17 Million |
| Selling, General and Administrative Expenses | 61.15 Million | 56.84 Million | 37.27 Million | 18.54 Million | 11.45 Million | 8.78 Million |
| Research and Development Expenses | 99.38 Million | 79.91 Million | 73.52 Million | 51.1 Million | 42.96 Million | 28.39 Million |
| Other Expenses | - | 1.16 Million | 657 Thousand | -37 Thousand | -53 Thousand | -1000.00 |
| Cost and Expenses | 162.47 Million | 138.26 Million | 112.27 Million | 69.65 Million | 54.42 Million | 37.17 Million |
| Operating Income | -131.48 Million | -112.78 Million | -96.93 Million | -67.93 Million | -54.42 Million | -37.17 Million |
| Interest Expense | 16.89 Million | 10.67 Million | 2.58 Million | - | - | - |
| Income Tax Expense | -1.53 Million | 3.38 Million | 2.88 Million | -833 Thousand | -354 Thousand | 453 Thousand |
| Earnings before Tax | -142.94 Million | -16.42 Million | -98.77 Million | -67.47 Million | -54.12 Million | -36.72 Million |
| Net Income | -141.4 Million | -19.81 Million | -101.66 Million | -66.64 Million | -53.76 Million | -36.72 Million |
| Earnings Per Share Basic | -2.63 | -0.51 | -2.77 | -2.44 | -3.95 | -3.59 |
| Earnings Per Share Diluted | -2.63 | -0.51 | -2.77 | -2.44 | -3.95 | -3.59 |
| Weighted Average Shares Outstanding | 53.74 Million | 39.07 Million | 36.69 Million | 27.27 Million | 13.62 Million | 10.22 Million |
| Weighted Average Shares Outstanding (Diluted) | 53.74 Million | 39.07 Million | 36.69 Million | 27.27 Million | 13.62 Million | 10.22 Million |
| Gross Margin | 0.94 | 0.99 | 0.90 | -28.40 | - | - |
| EBIT Margin | -4.05 | -0.23 | -6.27 | -39.54 | - | - |
| Profit Margin | -4.56 | -0.78 | -6.62 | -38.79 | - | - |
| EBITDA | -125.49 Million | -5.08 Million | -95.52 Million | -66.87 Million | -54.42 Million | -36.59 Million |
| Earnings Before Tax Margin | -4.24 | -4.43 | -6.32 | -39.54 | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 8.05 Million | 7.67 Million | 30.98 Million | 7.19 Million | 7.33 Million | 6.08 Million |
| Cost of Revenue | 875 Thousand | 887 Thousand | 2.48 Million | 1.01 Million | 455 Thousand | 386 Thousand |
| Gross Profit | 7.18 Million | 6.79 Million | 28.5 Million | 6.17 Million | 6.88 Million | 5.69 Million |
| Operating Expenses | 37.46 Million | 42.61 Million | 159.98 Million | 41.61 Million | 38.52 Million | 37.13 Million |
| Selling, General and Administrative Expenses | 16.71 Million | 18.62 Million | - | 15.35 Million | 14.86 Million | 15.72 Million |
| Research and Development Expenses | 20.75 Million | 23.98 Million | - | 26.25 Million | 23.66 Million | 21.41 Million |
| Other Expenses | -84 Thousand | 36 Thousand | -2.67 Million | -3.78 Million | 1.02 Million | 47 Thousand |
| Cost and Expenses | 38.34 Million | 43.5 Million | 162.47 Million | 42.62 Million | 38.98 Million | 37.52 Million |
| Operating Income | -30.28 Million | -35.82 Million | -131.48 Million | -35.43 Million | -31.64 Million | -31.43 Million |
| Interest Expense | 4.61 Million | 4.34 Million | 16.89 Million | 4.29 Million | -4.24 Million | 4.2 Million |
| Income Tax Expense | - | 87.72 Thousand | -1.53 Million | 3.37 Million | -142 Thousand | -1.53 Million |
| Earnings before Tax | -35.82 Million | -38.66 Million | -142.94 Million | -41.76 Million | -32.97 Million | -33.47 Million |
| Net Income | -35.82 Million | -38.66 Million | -141.4 Million | -41.76 Million | -32.97 Million | -31.93 Million |
| Earnings Per Share Basic | -0.63 | -0.68 | - | -0.74 | -0.61 | -0.61 |
| Earnings Per Share Diluted | -0.63 | -0.68 | - | -0.74 | -0.61 | -0.61 |
| Weighted Average Shares Outstanding | 57.06 Million | 56.85 Million | 53.74 Million | 56.68 Million | 53.92 Million | 52.55 Million |
| Weighted Average Shares Outstanding (Diluted) | 57.06 Million | 56.85 Million | 53.74 Million | 56.68 Million | 53.92 Million | 52.55 Million |
| Gross Margin | 0.89 | 0.88 | 0.92 | 0.86 | 0.94 | 0.94 |
| EBIT Margin | -3.74 | -4.65 | - | -4.91 | -4.31 | -4.79 |
| Profit Margin | -4.45 | -5.04 | -4.56 | -5.81 | -4.49 | -5.25 |
| EBITDA | -30.14 Million | -35.69 Million | - | -35.31 Million | -31.64 Million | -29.13 Million |
| Earnings Before Tax Margin | -3.76 | -4.66 | -4.24 | -4.93 | -4.31 | -5.17 |
NWFL
DFMTF
PDMI
FGPR
SMTOY
PAP